Addressing the R&D productivity challenge through big data
With an astonishing one million new articles being published every year, the wealth of knowledge now available to researchers is beginning to look more like a burden than a blessing. To locate relevant information buried in this data deluge, life science companies must invest in tools designed to uncover insights in big data and solutions that support early-stage drug discovery.
In this article published in Pharma Tech Outlook, you will discover:
- How access to data is crucial for mitigating risk in R&D
- Why pharmacovigilance and drug safety data is of particular value
- The role of text-mining tools and taxonomies in data searching
Learn how big data, when properly harnessed, can lead to confident decision-making and better return on investment in R&D.